Showing results (91-100 of 324) with videos related to

Sort By:
Pageof 33
European Journal of Cancer (Oxford, England : 1990)|March 2, 2002
Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomasM Van Glabbeke, J Verweij, I Judson, et al.
Seminars in Cancer Biology|December 1, 1992
Tyrosine kinase inhibitorsP Workman, V G Brunton, D J Robins
International Journal of Radiation Oncology, Biology, Physics|July 1, 1986
A phase I study of the combination of two hypoxic cell radiosensitizers, Ro 03-8799 and SR-2508: toxicity and pharmacokineticsH F Newman, N M Bleehen, P Workman
Biochemical Pharmacology|October 19, 1993
The efflux of anthracyclines in multidrug-resistant cell linesH M Coley, P R Twentyman, P Workman
International Journal of Radiation Oncology, Biology, Physics|April 1, 1989
Demonstration of tumor-selective retention of fluorinated nitroimidazole probes by 19F magnetic resonance spectroscopy in vivoR J Maxwell, P Workman, J R Griffiths
International Journal of Radiation Oncology, Biology, Physics|April 1, 1989
Molecular enzymology of the reductive bioactivation of hypoxic cell cytotoxinsM I Walton, C R Wolf, P Workman
British Journal of Cancer|May 1, 1989
Effects of localised tumour hyperthermia on pimonidazole (Ro 03-8799) pharmacokinetics in miceM I Walton, N M Bleehen, P Workman
Pageof 33